Coal India OFS Opens for Retail Investors Government to Sell Up to 2 Stake at 11 Discount Barnes Noble CEO James Daunt Clarifies Stance on AIWritten Books Emphasizes Publisher Responsibility Kevin Warsh Faces Divided Fed as Inflation Pressures Complicate Rate Cut Debate UK Chancellor Reeves Announces VAT Cut for Theme Parks and Childrens Meals to Ease CostofLiving Pressures NTPC Q4 Results Consolidated Profit Surges 34 YoY to 10615 Crore Board Declares 35Share Final Dividend Airtels Priority Plan Raises Concerns Over Tiered Internet Service Quality PHI Q1 2026 Earnings EPS Falls Slightly Short of Estimates Stock Edges Higher GLDD Q4 2025 Earnings Strong EPS Beat Driven by Operational Efficiency RKDA Q3 2025 Earnings Massive EPS Surprise Driven by NonOperating Gains Revenue Still Absent BioXcel Therapeutics BTAI Q1 2026 Earnings EPS Misses Expectations as PreRevenue Biotech Focuses on Pipeline Progress SSR Mining Q1 2026 Earnings EPS Surges Past Estimates by 318 as Stock Declines Allient Inc ALNT Q1 2026 Earnings EPS Misses Estimates but Stock Surges Over 12 Genuine Parts Company GPC Edges Lower as It Tests Key Support Zone INNOVATE Corp VATE Gains 374 as Price Approaches Key Resistance Level CMS Energy CMS Navigates Bearish Pressure Amidst Utility Sector Rotation Allstate ALL Holds Steady Near Key Support After Modest Pullback Neuberger Real Estate Securities Income Fund NRO Slips Amidst Modest Trading Activity Charter Communications Announces Enhanced Buyout Agreement for Liberty Broadband BAER Q1 2026 Earnings EPS Miss of 537 with Uptick in Stock Price Mount Logan Capital Gains 2 as Bulls Test Key Resistance Level Plumas Bancorp PLBC Edges Higher Testing Key Resistance After Modest Gain Greenfire Resources GFR Slides 299 as Shares Test Key Support Zone Quanex Building Products NX Rebounds 3 Approaching Key Resistance Level Ernexa Therapeutics Warrants ERNAW Slide Marginally to 015 Testing Key Support Zone SC II Acquisition Corp Units SCIIU Holds Steady at 1018 as SPAC Investors Await Catalyst Kodiak AI Inc KDK Slides Lower Key Support Levels in Focus After 27 Decline TG Therapeutics TGTX Slips Modestly as Stock Consolidates Near Key Support Levels